Cyclopharm sued by 4D Medical over webinar comments

Cyclopharm Limited confirmed on October 7, 2025, it has been served with legal proceedings initiated by 4D Medical Limited. The lawsuit alleges that comments made by Cyclopharm during its webinar presentation on March 19, 2025, concerning 4D Medical's capital raising statements, were false, misleading, or deceptive, and resulted in damages to 4D Medical.

Cyclopharm maintains the claim lacks merit. The ASX announcement regarding these proceedings was approved and authorized for release by James McBrayer, managing director, chief executive, and company secretary for Cyclopharm Limited.

For further information, interested parties can contact Mr. James McBrayer directly via telephone at +61 (02) 9541 0411.